UBS Group’s C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share CXAC.WS Stock Holding History

UBS Group’s Portfolio CXAC.WS Stock Details CXAC.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-117	Closed	-$5	–	10133
2023 Q1	$5	Sell	117 -1,465	-93%	-$51	﹤0.01%	9497
2022 Q4	$47	Buy	1,582 +131	+9%	+$6	﹤0.01%	10482
2022 Q3	$0	Sell	1,451 -100	-6%	-$17	﹤0.01%	11309
2022 Q2	$0	Buy	+1,551	New	+$395	﹤0.01%	11307

Other funds holding CXAC.WS

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

SCM

Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return

GAM

Gritstone Asset Management Bethesda, Maryland $93.6M AUM 11.18% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

UBS Group's CXAC.WS Position: Q2 2023 in Review

UBS Group sold out of C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (CXAC.WS) in Q2 2023, closing a stake of 117 shares — an estimated $5 sold.

UBS Group first reported a position in CXAC.WS in Q2 2022 and held it in 4 quarters. The position peaked at $47 in Q4 2022. 46 funds tracked by Wall St. Rank hold CXAC.WS as of Q2 2023.

UBS Group reported no remaining C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
UBS Group sold 117 C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q2 2023, an estimated $5.
UBS Group first reported a position in C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q2 2022 and held it in 4 quarters.
UBS Group's C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $47 in Q4 2022.
46 funds tracked by Wall St. Rank held C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q2 2023.

Based on UBS Group's 13F filing for Q2 2023, filed 11 Aug 2023.